LEUKERAN TABLETS 2 MG Israeli - Kiingereza - Ministry of Health

leukeran tablets 2 mg

padagis israel agencies ltd, israel - chlorambucil - tablets - chlorambucil 2 mg - chlorambucil - leukeran is indicated in the treatment of hodgkin's disease, indolent non-hodgkin's lymphoma, chronic lymphocytic leukaemia, and waldenstrom's macroglobulinaemia

ALKERAN TABLETS 2 MG Israeli - Kiingereza - Ministry of Health

alkeran tablets 2 mg

padagis israel agencies ltd, israel - melphalan - tablets - melphalan 2 mg - melphalan - melphalan - for the treatment of : multiple myeloma and advanced ovarian adenocarcinoma

TARDYFERON Israeli - Kiingereza - Ministry of Health

tardyferon

padagis israel agencies ltd, israel - ferrous sulfate - tablets - ferrous sulfate 247.25 mg - iron bivalent, oral preparations - prevention and treatment of iron deficiency anemia.

PERMIXON 160 MG Israeli - Kiingereza - Ministry of Health

permixon 160 mg

padagis israel agencies ltd, israel - lipidosterolic extract of serenoa repens - capsules - lipidosterolic extract of serenoa repens 160 mg - treatment of moderate micturation troubles related to benign hypertrophy of prostate in adult men.

MYLERAN TABLETS 2 MG Israeli - Kiingereza - Ministry of Health

myleran tablets 2 mg

padagis israel agencies ltd, israel - busulfan - tablets - busulfan 2 mg - busulfan - for the palliative treatment of the chronic granulocytic leukemia.

ARIXTRA 2.5 MG0.5 ML Israeli - Kiingereza - Ministry of Health

arixtra 2.5 mg0.5 ml

padagis israel agencies ltd, israel - fondaparinux sodium - solution for injection - fondaparinux sodium 5 mg / 1 ml - fondaparinux - fondaparinux - prevention of venous thromboembolic events (vte) in adults undergoing major orthopaedic surgery of the lower limbs such as hip fracture major knee surgery or hip replacement surgery. prevention of venous thromboembolic events (vte) in adults undergoing abdominal surgery who are judged to be at high risk of thromboembolic complications such as patients undergoing abdominal cancer surgery. prevention of venous thromboembolic events (vte) in adults medical patients who are judged to be at high risk for vte and who are immobilised due to acute illness such as cardiac insufficiency and/or acute respiratory disorders and/or acute infectious or inflammatory disease. treatment of unstable angina or non-st segment elevation myocardial infarcton (ua/nstemi) in adults for whom urgent ( < 120 mins) invasive management (pci) is not indicated . treatment of st segment elevation myocardial infarction (stemi) in patients who are managed with thrombolytics or who initially are to receive no other form of reperfusion therapy.

ARIXTRA 7.5 MG0.6 ML Israeli - Kiingereza - Ministry of Health

arixtra 7.5 mg0.6 ml

padagis israel agencies ltd, israel - fondaparinux sodium - solution for injection - fondaparinux sodium 12.5 mg/ml - fondaparinux - fondaparinux - treatment of adults with acute deep vein thrombosis (dvt) and treatment of acute pulmonary embolism (pe), except in haemodynamically unstable patients or patients who require thrombolysis or pulmonary embolectomy.

OVESTIN Israeli - Kiingereza - Ministry of Health

ovestin

padagis israel agencies ltd, israel - estriol - cream - estriol 0.1 % - estriol - for the treatment of vulvo-vaginal complaints related to estrogen deficiency.

TACROCEL 0.5 MG Israeli - Kiingereza - Ministry of Health

tacrocel 0.5 mg

padagis israel agencies ltd, israel - tacrolimus as monohydrate - capsules - tacrolimus as monohydrate 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immuonosuppressive medicinal products.

TACROCEL 1 MG Israeli - Kiingereza - Ministry of Health

tacrocel 1 mg

padagis israel agencies ltd, israel - tacrolimus as monohydrate - capsules - tacrolimus as monohydrate 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immuonosuppressive medicinal products.